These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33812214)

  • 1. Combination of polycarboxybetaine coating and factor XII inhibitor reduces clot formation while preserving normal tissue coagulation during extracorporeal life support.
    Naito N; Ukita R; Wilbs J; Wu K; Lin X; Carleton NM; Roberts K; Jiang S; Heinis C; Cook KE
    Biomaterials; 2021 May; 272():120778. PubMed ID: 33812214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zwitterionic poly-carboxybetaine coating reduces artificial lung thrombosis in sheep and rabbits.
    Ukita R; Wu K; Lin X; Carleton NM; Naito N; Lai A; Do-Nguyen CC; Demarest CT; Jiang S; Cook KE
    Acta Biomater; 2019 Jul; 92():71-81. PubMed ID: 31082571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs.
    Wilbs J; Kong XD; Middendorp SJ; Prince R; Cooke A; Demarest CT; Abdelhafez MM; Roberts K; Umei N; Gonschorek P; Lamers C; Deyle K; Rieben R; Cook KE; Angelillo-Scherrer A; Heinis C
    Nat Commun; 2020 Aug; 11(1):3890. PubMed ID: 32753636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII Silencing Using siRNA Prevents Thrombus Formation in a Rat Model of Extracorporeal Life Support.
    Umei N; Shin S; Lai A; Miller J; Roberts K; Strelkova D; Chaudhary N; Ichiba S; Sakamoto A; Whitehead K; Cook K
    ASAIO J; 2023 Jun; 69(6):527-532. PubMed ID: 36728837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study.
    Roberts TR; Harea GT; Singha P; Sieck KN; Beely BM; Wendorff DS; Choi JH; Ande S; Handa H; Batchinsky AI
    ASAIO J; 2020 Jul; 66(7):809-817. PubMed ID: 31453831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood.
    Gerling K; Ölschläger S; Avci-Adali M; Neumann B; Schweizer E; Schlensak C; Wendel HP; Stoppelkamp S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32668719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tethered Liquid Perfluorocarbon Coating for 72 Hour Heparin-Free Extracorporeal Life Support.
    Roberts TR; Choi JH; Wendorff DS; Harea GT; Beely BM; Sieck KN; Douglass ME; Singha P; Dean JB; Handa H; Batchinsky AI
    ASAIO J; 2021 Jul; 67(7):798-808. PubMed ID: 33534236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.
    Silvetti S; Koster A; Pappalardo F
    Artif Organs; 2015 Feb; 39(2):176-9. PubMed ID: 25041628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane Oxygenation.
    Buchtele N; Schwameis M; Schellongowski P; Quehenberger P; Knöbl P; Traby L; Schmid M; Schoergenhofer C; Herkner H; Jilma B; Staudinger T
    Crit Care Med; 2021 Dec; 49(12):e1206-e1211. PubMed ID: 34259662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation.
    Bartlett R; Arachichilage DJ; Chitlur M; Hui SR; Neunert C; Doyle A; Retter A; Hunt BJ; Lim HS; Saini A; Renné T; Kostousov V; Teruya J
    Semin Thromb Hemost; 2024 Feb; 50(1):81-90. PubMed ID: 36750217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII: a drug target for safe interference with thrombosis and inflammation.
    Kenne E; Renné T
    Drug Discov Today; 2014 Sep; 19(9):1459-64. PubMed ID: 24993156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance among assays for monitoring? Anticoagulation during extracorporeal life support.
    Scott EJ; Rotar E; Dahl JJ; Beller JP; Money DT; Chancellor WZ; Mehaffey JH; Morisette M; Yarboro LT; Teman NR
    Perfusion; 2023 Nov; 38(8):1714-1721. PubMed ID: 36167522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thrombogenic Surface Coatings for Extracorporeal Membrane Oxygenation: A Narrative Review.
    Zhang M; Pauls JP; Bartnikowski N; Haymet AB; Chan CHH; Suen JY; Schneider B; Ki KK; Whittaker AK; Dargusch MS; Fraser JF
    ACS Biomater Sci Eng; 2021 Sep; 7(9):4402-4419. PubMed ID: 34436868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
    Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
    Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
    Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
    Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nitric oxide on coagulation and inflammation in ex vivo models of extracorporeal membrane oxygenation and cardiopulmonary bypass.
    Malfertheiner MV; Garrett A; Passmore M; Haymet AB; Webb RI; Von Bahr V; Millar JE; Schneider BA; Obonyo NG; Black D; Bouquet M; Bartnikowski N; Suen JY; Fraser JF
    Artif Organs; 2023 Oct; 47(10):1581-1591. PubMed ID: 37395735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 72-Hour in vivo evaluation of nitric oxide generating artificial lung gas exchange fibers in sheep.
    Lai A; Demarest CT; Do-Nguyen CC; Ukita R; Skoog DJ; Carleton NM; Amoako KA; Montoya PJ; Cook KE
    Acta Biomater; 2019 May; 90():122-131. PubMed ID: 30953800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.